The 7 phosphoinositides (PIs) and their metabolism. The PI molecule includes inositol 1-phosphate (a hydrophilic portion exposed to the cytosol) bound via the phosphate group to 1-R1, 2-R2 diacylglycerol (a hydrophobic membrane-anchored portion). Depicted are the major pathways for synthesis and turnover confirmed both in vitro and in vivo (solid arrows). The routes implicated in insulin-regulated glucose transporter 4 (GLUT4) vesicle translocation discussed herein are in gray arrows. R1/R2, fatty acid; P, phosphate; PI3K, PI4K, and PI5K, PI 3-kinase, PI 4-kinase, and PI 5-kinase, respectively; PtdIns 4K, phosphatidylinositol 4-kinase; MTM, myotubularin; MTMR, myotubularin related; IpgD, entry-mediating invasin phosphatase; OCRL, phosphatase implicated in the oculocerebrorenal syndrome of Lowe; PtdIns(3)P, phosphatidylinositol 3-phosphate; PtdIns(3,5)P2, phosphatidylinositol 3,5-bisphosphate; PtdIns(5)P, phosphatidylinositol 5-phosphate; PtdIns(4,5)P2, phosphatidylinositol 4,5-bisphosphate; PTEN, phosphatase and tensin homolog deleted on chromosome 10; PIKfyve, phosphoinositide kinase for position five containing the FYVE domain; SHIP2, Src homology 2 containing inositol 5-phosphatase; SKIP, skeletal muscle- and kidney-enriched inositol phosphatase; PtdIns(3,4,5)P3, phosphatidylinositol 3,4,5-trisphosphate; PtdIns(4)P, phosphatidylinositol 4-phosphate; PtdIns(3,4)P2, phosphatidylinositol 3,4-bisphosphate.